Puissance Capital Management

Latest statistics and disclosures from Puissance Capital Management's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are BLPH, EKSO, SCYX, Kadmon Hldgs, CRVS, and represent 100.00% of Puissance Capital Management's stock portfolio.
  • Added to shares of these 2 stocks: SCYX, Kadmon Hldgs.
  • Started 2 new stock positions in Kadmon Hldgs, SCYX.
  • Reduced shares in these 1 stock: Scynexis.
  • Sold out of its position in Scynexis.
  • Puissance Capital Management was a net seller of stock by $-571k.
  • Puissance Capital Management has $17M in assets under management (AUM), dropping by -25.97%.
  • Central Index Key (CIK): 0001658437

Tip: Access up to 7 years of quarterly data

Positions held by Puissance Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Puissance Capital Management

Puissance Capital Management holds 5 positions in its portfolio as reported in the September 2020 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Bellerophon Therapeutics Com New (BLPH) 67.7 $12M 1.2M 10.18
 View chart
Ekso Bionics Hldgs (EKSO) 21.2 $3.7M 774k 4.75
 View chart
Scynexis Com New (SCYX) 7.9 $1.4M NEW 311k 4.41
 View chart
Kadmon Hldgs 2.3 $393k NEW 100k 3.92
 View chart
Corvus Pharmaceuticals (CRVS) 0.9 $152k 38k 4.00
 View chart

Past Filings by Puissance Capital Management

SEC 13F filings are viewable for Puissance Capital Management going back to 2017